173 related articles for article (PubMed ID: 38619252)
21. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
[TBL] [Abstract][Full Text] [Related]
22. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients.
Mitterreiter JG; Titulaer MJ; van Nierop GP; van Kampen JJ; Aron GI; Osterhaus AD; Verjans GM; Ouwendijk WJ
PLoS One; 2016; 11(5):e0155531. PubMed ID: 27171421
[TBL] [Abstract][Full Text] [Related]
24. Contribution of a combination of ponicidin and acyclovir/ganciclovir to the antitumor efficacy of the herpes simplex virus thymidine kinase gene therapy system.
Hayashi K; Hayashi T; Sun HD; Takeda Y
Hum Gene Ther; 2002 Feb; 13(3):415-23. PubMed ID: 11860708
[TBL] [Abstract][Full Text] [Related]
25. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals.
van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM
J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of mutations in DNA polymerase and thymidine kinase genes of herpes simplex virus clinical isolates resistant to antiherpetic drugs].
Korovina AN; Gus'kova AA; Skoblov MIu; Andronova VL; Galegov GA; Kochetkov SN; Kukhanova MK; Skoblov IuS
Mol Biol (Mosk); 2010; 44(3):488-96. PubMed ID: 20608173
[TBL] [Abstract][Full Text] [Related]
27. Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance.
Schmidt S; Bohn-Wippert K; Schlattmann P; Zell R; Sauerbrei A
Antimicrob Agents Chemother; 2015 Aug; 59(8):4938-45. PubMed ID: 26055375
[TBL] [Abstract][Full Text] [Related]
28. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.
Suzutani T; Ishioka K; De Clercq E; Ishibashi K; Kaneko H; Kira T; Hashimoto K; Ogasawara M; Ohtani K; Wakamiya N; Saijo M
Antimicrob Agents Chemother; 2003 May; 47(5):1707-13. PubMed ID: 12709344
[TBL] [Abstract][Full Text] [Related]
29. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa.
Muller EE; Maseko DV; Kularatne RS
Antiviral Res; 2022 Apr; 200():105277. PubMed ID: 35271913
[TBL] [Abstract][Full Text] [Related]
31. Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin.
Hayashi K; Hayashi T; Sun HD; Takeda Y
Cancer Gene Ther; 2000 Jan; 7(1):45-52. PubMed ID: 10678355
[TBL] [Abstract][Full Text] [Related]
32. Hydroxyurea potentiates the antiherpesvirus activities of purine and pyrimidine nucleoside and nucleoside phosphonate analogs.
Neyts J; De Clercq E
Antimicrob Agents Chemother; 1999 Dec; 43(12):2885-92. PubMed ID: 10582877
[TBL] [Abstract][Full Text] [Related]
33. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of resistance to acyclovir in thymidine kinase mutants from Herpes simplex virus type 1: a computational approach.
Rabelo VW; Romeiro NC; Paixão ICNP; Abreu PA
J Biomol Struct Dyn; 2020 Apr; 38(7):2116-2127. PubMed ID: 31190614
[TBL] [Abstract][Full Text] [Related]
35. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
[TBL] [Abstract][Full Text] [Related]
36. Thymidine kinase mutations conferring acyclovir resistance in herpes simplex type 1 recombinant viruses.
Sergerie Y; Boivin G
Antimicrob Agents Chemother; 2006 Nov; 50(11):3889-92. PubMed ID: 16982796
[TBL] [Abstract][Full Text] [Related]
37. Acyclovir-Resistant Herpes Simplex Virus 1 Keratitis: A Concerning and Emerging Clinical Challenge.
Rousseau A; Pharm SB; Gueudry J; Deback C; Haigh O; Schweitzer C; Boutolleau D; Labetoulle M
Am J Ophthalmol; 2022 Jun; 238():110-119. PubMed ID: 35033543
[TBL] [Abstract][Full Text] [Related]
38. Acyclovir-resistant HSV-1 isolates among immunocompromised patients in southern Taiwan: Low prevalence and novel mutations.
Kuo JY; Yeh CS; Wang SM; Chen SH; Wang JR; Chen TY; Tsai HP
J Med Virol; 2023 Aug; 95(8):e28985. PubMed ID: 37505438
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.
Focher F; Lossani A; Verri A; Spadari S; Maioli A; Gambino JJ; Wright GE; Eberle R; Black DH; Medveczky P; Medveczky M; Shugar D
Antimicrob Agents Chemother; 2007 Jun; 51(6):2028-34. PubMed ID: 17438061
[TBL] [Abstract][Full Text] [Related]
40. [Adenovirus-mediated herpes simplex virus thymidine kinase gene transference and combined drug therapy leads to apoptosis of human epithelial ovarian cancer cells].
Jiang J; Kong B; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2000 Dec; 35(12):736-9. PubMed ID: 11286034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
